Soufflé Therapeutics Raises $135 Million in Series B Round for RNA Therapies
Soufflé Therapeutics, a biotechnology company developing next-generation RNA therapies, has raised $135 million in an oversubscribed Series B funding round to advance its drug development programs and expand its pipeline.…